nanoliposomal irinotecan
Showing 1 - 25 of 1,106
Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in
Not yet recruiting
- Pancreatic Adenocarcinoma Metastatic
-
Pessac, FranceCHU Bordeaux
Aug 17, 2023
Pancreatic Ductal Adenocarcinoma Trial in United States (Onvansertib, Nanoliposomal irinotecan, Leucovorin)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Onvansertib
- +3 more
-
Phoenix, Arizona
- +5 more
Dec 15, 2022
Metastatic Pancreatic Cancer Trial (nanoliposomal irinotecan, spleen irradiation)
Not yet recruiting
- Metastatic Pancreatic Cancer
- nanoliposomal irinotecan
- spleen irradiation
- (no location specified)
May 8, 2022
Peritoneal Carcinomatosis, Peritoneal Metastases, Colorectal Cancer Trial in Ghent (PIPAC with Nal-IRI)
Recruiting
- Peritoneal Carcinomatosis
- +7 more
- PIPAC with Nal-IRI
-
Ghent, East-Flanders, BelgiumUZ Ghent
Dec 28, 2022
Metastatic Pancreatic Cancer Trial (Olaptesed pegol)
Not yet recruiting
- Metastatic Pancreatic Cancer
- Olaptesed pegol
- (no location specified)
Jul 19, 2022
Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal
Recruiting
- Colorectal Adenocarcinoma
- +13 more
- Nanoliposomal Irinotecan
- Trifluridine and Tipiracil Hydrochloride
-
Atlanta, Georgia
- +2 more
Jan 6, 2023
Peritoneal Cancer, Pseudomyxoma Peritonei, Mucinous Adenocarcinoma Trial in Lexington, Stony Brook (nanoliposomal irinotecan)
Completed
- Peritoneal Cancer
- +7 more
- nanoliposomal irinotecan
-
Lexington, Kentucky
- +1 more
May 5, 2022
Biliary Tract Cancer Trial in United States (Nivolumab, Nanoliposomal-Irinotecan, 5-Fluorouracil)
Active, not recruiting
- Biliary Tract Cancer
- Nivolumab
- +3 more
-
Ann Arbor, Michigan
- +4 more
Oct 6, 2022
Advanced Biliary Tract Cancer Trial in Washington, Indianapolis, Saint Louis (Nanoliposomal Irinotecan, Leucovorin,
Recruiting
- Advanced Biliary Tract Cancer
- Nanoliposomal Irinotecan
- +2 more
-
Washington, District of Columbia
- +2 more
Oct 29, 2021
Refractory Solid Tumors Trial in Taichung, Tainan (Nanoliposomal Irinotecan)
Active, not recruiting
- Refractory Solid Tumors
- Nanoliposomal Irinotecan
-
Taichung, Taiwan
- +1 more
Sep 16, 2021
Malignant Solid Tumor Trial in United States (drug, other, procedure)
Active, not recruiting
- Malignant Solid Neoplasm
- Ferumoxytol
- +4 more
-
Baltimore, Maryland
- +5 more
Nov 8, 2022
High Grade Glioma Trial in San Francisco (nanoliposomal irinotecan)
Active, not recruiting
- High Grade Glioma
- nanoliposomal irinotecan
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 26, 2021
Tolerability of Liposomal Irinotecan
Active, not recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- Onivyde® + 5-FULV
-
Edegem, BelgiumAntwerp University Hosptital
Jan 31, 2022
Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal
Completed
- Platinum-Resistant Fallopian Tube Carcinoma
- +8 more
- Bevacizumab
- Irinotecan Sucrosofate
-
Chicago, IllinoisNorthwestern University
Dec 21, 2022
Head & Neck Cancer Trial in Taichung, Tainan, Taipei (nanoliposomal irinotecan)
Active, not recruiting
- Head & Neck Cancer
- nanoliposomal irinotecan
-
Taichung, Taiwan
- +3 more
Mar 25, 2021
GEP-NET Trial in Taiwan (nanoliposomal irinotecan plus carboplatin)
Not yet recruiting
- GEP-NET
- nanoliposomal irinotecan plus carboplatin
-
Kaohsiung, Taiwan
- +5 more
May 17, 2022
Metastatic Pancreatic Ductal Adenocarcinoma Trial in Belgium (Nanoliposomal irinotecan, 5 FU, Leucovorin)
Recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- Nanoliposomal irinotecan
- +3 more
-
Brugge, West-Vlaanderen, Belgium
- +11 more
Jul 25, 2022
Pancreatic Adenocarcinoma Trial in Seattle (Gemcitabine, nab paclitaxel, Onivyde)
Recruiting
- Pancreatic Adenocarcinoma
- Gemcitabine
- +4 more
-
Seattle, WashingtonVirginia mason medical Center
Jan 25, 2021
Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in United States (Fluorouracil, Gemcitabine,
Recruiting
- Metastatic Pancreatic Adenocarcinoma
- Stage IV Pancreatic Cancer AJCC v8
- Fluorouracil
- +8 more
-
Boise, Idaho
- +42 more
Jun 8, 2022
Locally Advanced Unresectable Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma, Metastatic
Withdrawn
- Locally Advanced Unresectable Gastric Adenocarcinoma
- +5 more
- Liposomal Irinotecan
- +3 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Mar 25, 2020
Solid Tumors, ER/PR Positive Breast Cancer, Triple Negative Breast Cancer Trial in United States (Ferumoxytol, MM-398)
Completed
- Solid Tumors
- +3 more
-
Scottsdale, Arizona
- +6 more
Nov 15, 2019
Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,
Not yet recruiting
- Metastatic Gastric Adenocarcinoma
- +2 more
- nal-IRI /Experimental
- +2 more
- (no location specified)
Jun 25, 2023